Skip to content

Characterization of intestinal microbiota and probiotics treatment in children with autism spectrum disorders in China

Study for gut microbiota in children with aseautistic spectrum disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023609
Enrollment
Unknown
Registered
2019-06-04
Start date
2017-11-08
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autistic Spectrum Disorder

Interventions

ASD group:Oral probiotics
Typically development group:Oral probiotics

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 8 Years

Inclusion criteria

Inclusion criteria: ASD enrollment criteria: 1. diagnosis of ASD according to DSM-V; 2. aged 3-8 years old; 3. no kinship between participants. NT children were selected using the following criteria: 1. aged 3-8 years old, normal development; 2. no family history of ASD; 3. children guardians agreed to participate in the study and signed informed consent; 4. no antibiotics, or other gastrointestinal treatments within 1 month before enrollment.

Exclusion criteria

Exclusion criteria: ASD group: 1. Used antibiotics, probiotics, or other gastrointestinal treatments within 1 month prior to enrollment; 2. children with other mental illnesses, brain organic disease, severe liver and kidney diseases, and cardiovascular diseases; 3. children guardians did not give permission for participation or did not complete follow-up.

Design outcomes

Primary

MeasureTime frame
ATEC score;

Secondary

MeasureTime frame
gut microbiota structure;

Countries

China

Contacts

Public ContactYing Han

Department of Pediatrics, Peking University First Hospital

hanying1568@126.com+86 13661013288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026